North America, Europe, and Asia-Pacific Large Molecule Bioanalysis Testing Services Market Research Report Forecast to 2030

PUBLISHED: January 15, 2024

PAGES: 145 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The market for large molecule bioanalysis testing services in North America, Europe, and Asia-Pacific is expanding due to rising demand for high-tech and dependable large molecule bioanalytical testing services, a growing trend of outsourcing laboratory testing services, and an increase in the number of clinical trials. However, the difficulties in developing appropriate analytical techniques are limiting the growth of the North America, Europe, and Asia-Pacific large molecule bioanalysis testing services market. Furthermore, the growing prevalence of chronic diseases is expected to provide lucrative growth opportunities for the North America, Europe, and Asia-Pacific large molecule bioanalysis testing services market.

The concentration of large molecules in biological samples such as proteins and antibodies are determined using large molecule bioanalytical testing services. Large molecules are frequently utilized in drug development, and bioanalytical testing is required to ensure these drugs' safety and efficacy.

The expected growth in market can be attributed to the increasing demand for high-tech and reliable large molecule bioanalytical testing services, growing trend of outsourcing laboratory testing services, and rising R&D expenditure in the biopharmaceutical sector. However, the market is also held back by challenges in the development of proper analytical techniques. Nevertheless, it is anticipated that the growing incidence of chronic diseases will create lucrative opportunities for the players operating in the North America, Europe, And Asia-Pacific large molecule bioanalysis testing services market.

MARKET SEGMENTATION

Based on test type, the large molecule bioanalysis testing market has been segmented into pharmacokinetic (PK) studies, pharmacodynamic studies, bioequivalence studies, immunogenicity testing, biomarker testing and others.

Based on therapeutic area, the market has been segmented into oncology, infectious diseases, cardiovascular diseases, neurology, autoimmune disorders, and others.

Based on test type, the market has been segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), academic and research institutes, and others.

Regional Analysis

Based on region, the large molecule bioanalysis testing services market has been segmented into North America, Europe, and Asia-Pacific. North America accounted for the largest market share of 45.29% in 2022 and is anticipated to reach approximately USD 1,498.85 million by 2030 at an 8.70% CAGR during the forecast period. However, Asia-Pacific is projected to register the highest CAGR of 11.52% by 2030.

MAJOR PLAYERS

America Holdings (US), ICON plc (Ireland), SGS Societe Generale de Surveillance SA (Switzerland), WuXi AppTec (China), Charles River Laboratories (US), Eurofins Scientific (luxembourg), QPS Holdings (US), BioTechne (US), PPD, Inc (US), BioAgilytix Labs (US), Smithers (US), Meso Scale Diagnostic, LLC (US), and CMIC HOLDINGS CO., LTD (Japan).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING DEMAND FOR HIGH-TECH AND RELIABLE LARGE MOLECULE BIOANALYTICAL TESTING SERVICES
- 4.2.2 GROWING TREND OF OUTSOURCING LABORATORY TESTING SERVICES
- 4.2.3 RISING R&D EXPENDITURE IN THE BIOPHARMACEUTICAL SECTOR
4.3 RESTRAINTS
- 4.3.1 CHALLENGES IN THE DEVELOPMENT OF PROPER ANALYTICAL TECHNIQUES
4.4 OPPORTUNITIES
- 4.4.1 GROWING INCIDENCE OF CHRONIC DISEASES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 CUSTOMER ACQUISITION (PRE-PURCHASE QUERY)
- 5.1.2 SERVICE CUSTOMIZATION
- 5.1.3 CUSTOMER PURCHASE SUPPORT
- 5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON SERVICE PROVIDER

6 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE

6.1 OVERVIEW
6.2 PHARMACOKINETIC (PK) STUDIES
6.3 PHARMACODYNAMIC (PD) STUDIES
6.4 BIOEQUIVALENCE STUDIES
6.5 BIOMARKER TESTING
6.6 IMMUNOGENICITY TESTING
6.7 OTHERS

7 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA

7.1 OVERVIEW
7.2 ONCOLOGY
7.3 INFECTIOUS DISEASES
7.4 CARDIOVASCULAR DISEASE
7.5 NEUROLOGY
7.6 AUTOIMMUNE DISORDERS
7.7 OTHERS

8 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER

8.1 OVERVIEW
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS)
8.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.5 ACADEMIC AND RESEARCH INSTITUTES
8.6 OTHERS

9 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 SWITZERLAND
- 9.3.7 NETHERLANDS
- 9.3.8 BELGIUM
- 9.3.9 SWEDEN
- 9.3.10 NORWAY
- 9.3.11 DENMARK
- 9.3.12 IRELAND
- 9.3.13 FINLAND
- 9.3.14 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA-PACIFIC

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CATEGORY
- 10.3.1 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY PHARMA
- 10.3.2 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CDMO
- 10.3.3 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CRO
- 10.3.4 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY ACADEMIC AND RESEARCH INSTITUTIONS
10.4 MAJOR GROWTH STRATEGY IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET
10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET
10.6 KEY DEVELOPMENT ANALYSIS
10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.7.1 EXPANSION
10.8 MAJOR PLAYERS FINANCIAL
- 10.8.1 SALES (USD MILLION), 2022
- 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

11.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 SERVICES OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 PPD INC
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 SERVICES OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 EUROFINS SCIENTIFIC
- 11.3.1 COMPANY OVERVIEWS
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 SERVICES OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 WUXI APPTEC
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 QPS HOLDINGS
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
11.6 BIO-TECHNE
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 SERVICES OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 KEY STRATEGIES
11.7 ICON PLC
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 SERVICES OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 CHARLES RIVER LABORATORIES
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 SERVICES OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 SGS SOCIETE GENERALE DE SURVEILLANCE SA
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS/SERVICES OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 BIOAGILYTIX LABS
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 SERVICES OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
11.11 SMITHERS
- 11.11.1 COMPANY OVERVIEW
- 11.11.2 FINANCIAL ANALYSIS
- 11.11.3 SERVICES OFFERED
- 11.11.4 KEY DEVELOPMENTS
- 11.11.5 KEY STRATEGIES
11.12 MESO SCALE DIAGNOSTICS, LLC
- 11.12.1 COMPANY OVERVIEW
- 11.12.2 FINANCIAL ANALYSIS
- 11.12.3 SERVICES OFFERED
- 11.12.4 KEY DEVELOPMENTS
- 11.12.5 KEY STRATEGIES
11.13 CMIC HOLDINGS CO., LTD
- 11.13.1 COMPANY OVERVIEW
- 11.13.2 FINANCIAL OVERVIEW
- 11.13.3 SERVICES OFFERED
- 11.13.4 KEY DEVELOPMENTS
- 11.13.5 KEY STRATEGIES

12 REFERENCES

12.1 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 20
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
TABLE 3 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2032 (USD MILLION) 39
TABLE 4 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACOKINETIC (PK) STUDIES, BY REGION 2019-2032 (USD MILLION) 40
TABLE 5 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACODYNAMIC (PD) STUDIES, BY REGION 2019-2032 (USD MILLION) 41
TABLE 6 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR BIOEQUIVALENCE STUDIES, BY REGION 2019-2032 (USD MILLION) 41
TABLE 7 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR BIOMARKER TESTING, BY REGION 2019-2032 (USD MILLION) 42
TABLE 8 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR IMMUNOGENICITY TESTING, BY REGION 2019-2032 (USD MILLION) 42
TABLE 9 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019-2032 (USD MILLION) 43
TABLE 10 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD MILLION) 45
TABLE 11 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR ONCOLOGY, BY REGION 2019-2032 (USD MILLION) 46
TABLE 12 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR INFECTIOUS DISEASES, BY REGION 2019-2032 (USD MILLION) 47
TABLE 13 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CARDIOVASCULAR DISEASE, BY REGION 2019-2032(USD MILLION) 47
TABLE 14 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR NEUROLOGY, BY REGION 2019-2032(USD MILLION) 47
TABLE 15 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR AUTOIMMUNE DISORDERS, BY REGION 2019-2032(USD MILLION) 48
TABLE 16 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019-2032(USD MILLION) 48
TABLE 17 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER, 2019-2032(USD MILLION) 50
TABLE 18 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION 2019-2032 (USD MILLION) 51
TABLE 19 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), BY REGION 2019-2032 (USD MILLION) 52
TABLE 20 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION 2019-2032 (USD MILLION) 52
TABLE 21 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION 2019-2032 (USD MILLION) 53
TABLE 22 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019-2032 (USD MILLION) 53
TABLE 23 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2019-2030 (USD MILLION) 55
TABLE 24 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 56
TABLE 25 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 56
TABLE 26 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 57
TABLE 27 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 59
TABLE 28 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 60
TABLE 29 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 60
TABLE 30 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 61
TABLE 31 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 61
TABLE 32 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 62
TABLE 33 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 62
TABLE 34 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 63
TABLE 35 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 63
TABLE 36 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 64
TABLE 37 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 67
TABLE 38 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 68
TABLE 39 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 68
TABLE 40 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 69
TABLE 41 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 69
TABLE 42 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 70
TABLE 43 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 70
TABLE 44 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 71
TABLE 45 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 71
TABLE 46 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 72
TABLE 47 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 72
TABLE 48 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 73
TABLE 49 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 73
TABLE 50 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 74
TABLE 51 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 74
TABLE 52 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 75
TABLE 53 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 75
TABLE 54 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 76
TABLE 55 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 76
TABLE 56 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 77
TABLE 57 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 77
TABLE 58 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 78
TABLE 59 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 78
TABLE 60 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 79
TABLE 61 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 79
TABLE 62 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 80
TABLE 63 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 80
TABLE 64 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 81
TABLE 65 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 81
TABLE 66 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 82
TABLE 67 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 82
TABLE 68 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 83
TABLE 69 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 83
TABLE 70 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 84
TABLE 71 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 84
TABLE 72 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 85
TABLE 73 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 85
TABLE 74 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 86
TABLE 75 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 86
TABLE 76 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 87
TABLE 77 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 87
TABLE 78 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 88
TABLE 79 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 88
TABLE 80 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 89
TABLE 81 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 89
TABLE 82 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 90
TABLE 83 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 93
TABLE 84 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 93
TABLE 85 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 94
TABLE 86 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 94
TABLE 87 CHINA 95
TABLE 88 CHINA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 95
TABLE 89 CHINA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 96
TABLE 90 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 96
TABLE 91 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 97
TABLE 92 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 97
TABLE 93 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 98
TABLE 94 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 98
TABLE 95 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 99
TABLE 96 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 99
TABLE 97 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 100
TABLE 98 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 100
TABLE 99 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 101
TABLE 100 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 101
TABLE 101 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 102
TABLE 102 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 102
TABLE 103 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 103
TABLE 104 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 103
TABLE 105 MAJOR PLAYERS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 105
TABLE 106 TOP 10 PHARMA COMPANIES FOR LARGE MOLECULE BIOANALYSIS 106
TABLE 107 TOP 10 CDMO COMPANIES FOR LARGE MOLECULE BIOANALYSIS 107
TABLE 108 TOP 10 CRO COMPANIES FOR LARGE MOLECULE BIOANALYSIS 107
TABLE 109 TOP 10 ACADEMIC AND RESEARCH INSTITUTIONS FOR LARGE MOLECULE BIOANALYSIS 108
TABLE 110 MOST ACTIVE PLAYER IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 109
TABLE 111 EXPANSION 110
TABLE 112 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED 113
TABLE 113 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS 114
TABLE 114 PPD INC: SERVICES OFFERED 115
TABLE 115 PPD INC: KEY DEVELOPMENTS 115
TABLE 116 EUROFINS SCIENTIFIC: SERVICES OFFERED 118
TABLE 117 WUXI APPTEC: SERVICES OFFERED 122
TABLE 118 QPS HOLDINGS: SERVICES OFFERED 123
TABLE 119 QPS HOLDINGS: KEY DEVELOPMENTS 123
TABLE 120 BIOTECHNE: SERVICES OFFERED 126
TABLE 121 ICON PLC: SERVICES OFFERED 129
TABLE 122 CHARLES RIVER LABORATORIES: SERVICES OFFERED 133
TABLE 123 SGS SOCIETE GENRALE DE SURVEILLANCE SA: PRODUCTS/SERVICES OFFERED 136
TABLE 124 BIOAGILYTIX LABS: SERVICES OFFERED 137
TABLE 125 SMITHERS: SERVICES OFFERED 138
TABLE 126 MESO SCALE DIAGNOSTIC, LLC: SERVICES OFFERED 139
TABLE 127 CMIC HOLDINGS CO., LTD: SERVICES OFFERED 141

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 18
FIGURE 2 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 20
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 26
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 29
FIGURE 5 DRIVER IMPACT ANALYSIS 31
FIGURE 6 RESTRAINT IMPACT ANALYSIS 32
FIGURE 7 VALUE CHAIN ANALYSIS: NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 33
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 35
FIGURE 9 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, TEST TYPE, SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 38
FIGURE 10 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2022 & 2032 (USD MILLION) 39
FIGURE 11 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY TEST TYPE, 2022 (%) 40
FIGURE 12 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, THERAPEUTIC AREA, SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 44
FIGURE 13 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2022 & 2032 (USD MILLION) 45
FIGURE 14 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY THERAPEUTIC AREA, 2022 (%) 46
FIGURE 15 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 49
FIGURE 16 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER, 2022 & 2032 (USD MILLION) 50
FIGURE 17 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY END USER, 2022 (%) 51
FIGURE 18 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022 & 2030 (USD MILLION) 54
FIGURE 19 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY REGION, 2022 (% SHARE) 55
FIGURE 20 NORTH AMERICA MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 58
FIGURE 21 NORTH AMERICA: LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 59
FIGURE 22 NORTH AMERICA: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY REGION, 2022 (% SHARE) 59
FIGURE 23 EUROPE MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 65
FIGURE 24 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 66
FIGURE 25 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE (%), BY COUNTRY, 2022 67
FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 91
FIGURE 27 ASIA-PACIFIC: LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 92
FIGURE 28 ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 92
FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS 106
FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 108
FIGURE 31 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET: COMPETITIVE LANDSCAPE 110
FIGURE 32 MAJOR PLAYERS SALES (USD MILLION), 2022 111
FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2022 111
FIGURE 34 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT 113
FIGURE 35 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS 114
FIGURE 36 PPD INC: SWOT ANALYSIS 116
FIGURE 37 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 118
FIGURE 38 EUROFINS SCIENTIFIC: SWOT ANALYSIS 119
FIGURE 39 WUXI APPTEC: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 40 BIOTECHNE: FINANCIAL OVERVIEW SNAPSHOT 126
FIGURE 41 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT 129
FIGURE 42 ICON PLC: SWOT ANALYSIS 130
FIGURE 43 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 132
FIGURE 44 CHARLES RIVER LABORATORIES: SWOT ANALYSIS 134
FIGURE 45 SGS SOCIETE GENRALE DE SURVEILLANCE SA: FINANCIAL OVERVIEW SNAPSHOT 135
FIGURE 46 CMIC HOLDINGS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 140